Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

14.22
-0.0150-0.11%
Post-market: 14.280.0625+0.44%19:59 EDT
Volume:11.92M
Turnover:169.86M
Market Cap:6.44B
PE:-20.14
High:14.75
Open:14.45
Low:13.95
Close:14.23
52wk High:15.30
52wk Low:1.76
Shares:452.97M
Float Shares:394.00M
Volume Ratio:0.40
T/O Rate:3.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7058
EPS(LYR):-1.0941
ROE:-40.36%
ROA:-20.31%
PB:8.75
PE(LYR):-12.99

Loading ...

Iovance Biotherapeutics files automatic mixed securities shelf

TIPRANKS
·
Jun 19

Iovance Biotherapeutics Inc: Sale Agreement Prospectus Supplement Covering Offering of up to $89.7 Mln Common Stock

THOMSON REUTERS
·
Jun 19

Iovance Biotherapeutics Inc Files for Mixed Shelf - SEC Filing

THOMSON REUTERS
·
Jun 19

Iovance Biotherapeutics (IOVA) Stock Valuation After Australia’s Conditional Approval Of Amtagvi

Simply Wall St.
·
Jun 15

Iovance says Australia regulator approves Amtagvi for previously treated advanced melanoma

Reuters
·
Jun 11

Iovance’s Australian Amtagvi Nod Adds Test For Valuation Upside

Simply Wall St.
·
Jun 05

BRIEF-Iovance's Amtagvi Granted Approval For Treatment Of Advanced Melanoma In Australia

Reuters
·
Jun 04

Iovance receives Australian approval of Amtagvi for advanced melanoma

TIPRANKS
·
Jun 04

Australia TGA approves Iovance Amtagvi for previously treated advanced melanoma

Reuters
·
Jun 04

Iovance’s Amtagvi® (Lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

THOMSON REUTERS
·
Jun 04

Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

GlobeNewswire
·
Jun 04

Iovance gets allowance to proceed from FDA for IOV-5001 IND application

TIPRANKS
·
Jun 01

Iovance Biotherapeutics Receives US FDA Clearance to Begin IOV-5001 Trial in Solid Tumors

MT Newswires Live
·
Jun 01

Iovance says FDA clears IND for IL-12 tethered TIL therapy IOV-5001

Reuters
·
Jun 01

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (Ind) Application for Il-12 Tethered Til Therapy Iov-5001

THOMSON REUTERS
·
Jun 01

A Look At Iovance Biotherapeutics (IOVA) Valuation After Recent Share Price Recovery

Simply Wall St.
·
May 31

Iovance grants inducement stock options for 93,340 shares at $3.7 each

Reuters
·
May 23

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
May 23

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Black Diamond Therapeutics (BDTX) and Iovance Biotherapeutics (IOVA)

TIPRANKS
·
May 22

Can Iovance (IOVA) Turn Early Amtagvi Data and Manufacturing Tweaks into a Durable Advantage?

Simply Wall St.
·
May 22